Dermaprime Private Limited
About Dermaprime Private Limited
Data last updated:
Dermaprime Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 June 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2022PTC164298.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.5 Lakh. It is led by directors including Narasimhachary Chowdoju (Managing Director) and Anka Rao Pendyala.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 – 2 – 40/111/3 Gourinathapuram, Hyderabad, Telangana, India – 500062.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.52 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹5.15 Lakh (net margin 1.5%) and EBITDA of ₹7.83 Lakh (EBITDA margin 2.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address1 – 2 – 40/111/3 Gourinathapuram, Hyderabad, Telangana, India – 500062
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dermaprime Private Limited
The main business activity of Dermaprime is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dermaprime Private Limited FY 2025 filings available
Dermaprime Private Limited reported revenue of ₹3.52 Cr (down 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dermaprime Private Limited
Revenue fell 10% in the latest year. EBITDA fell 17% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Dermaprime Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹7.83 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.15 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Dermaprime Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2.2% | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dermaprime are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dermaprime Private Limited
Dermaprime Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Valcret Life Sciences Private Limited | ₹3.54 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Chandigarh, India |
| Bioshield Lifesciences Private Limited. | ₹3.54 Cr (FY 2024) | •••• | •••• | -25.0% | •••• | New Delhi, Delhi, India |
| Success Ceramic Private Limited | ₹3.54 Cr (FY 2024) | •••• | •••• | 1726.0% | •••• | Vaghasia, Gujarat, India |
| Delma Innovation Private Limited | ₹3.53 Cr (FY 2024) | •••• | •••• | 37.0% | •••• | Guwahati, Assam, India |
| Medorna Health Systems Private Limited | ₹3.52 Cr (FY 2024) | •••• | •••• | 32.0% | •••• | Bangalore, Karnataka, India |
| Dermaprime Private Limited this company | ₹3.52 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Hyderabad, Telangana, India |
| C.M. Arora Pharma Private Limited | ₹3.51 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Jaipur, Rajasthan, India |
| Strides Consumer Private Limited | ₹3.51 Cr (FY 2025) | •••• | •••• | -61.0% | •••• | Thane, Maharashtra, India |
| Vikshar Healthcare Private Limited | ₹3.5 Cr (FY 2025) | •••• | •••• | 86.0% | •••• | Mumbai, Maharashtra, India |
| Ranjana Healthcare Private Limited | ₹3.5 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Lucknow, Uttar Pradesh, India |
| Quimico Pharmaceuticals Private Limited | ₹3.5 Cr (FY 2024) | •••• | •••• | 50.0% | •••• | Jodhpur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Dermaprime by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Dermaprime Private Limited
Dermaprime has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narasimhachary Chowdoju | Managing Director | 30 Jun 2022 | 4 Years 3 Months | Current |
| Anka Rao Pendyala Also directs: Prime Ness Healthcare Private Limited | Director | 30 Jun 2022 | 4 Years 3 Months | Current |
| Channahalli Munivenkategowda Naveen Kumar Also directs: Triaxis Pharma Private Limited, Navraag Pharma Private Limited | Director | 30 Jun 2022 | 4 Years 3 Months | Current |
Charges & Borrowings of Dermaprime Private Limited
Dermaprime Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Dermaprime Private Limited
Employment history and EPFO contributions of people linked to Dermaprime.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dermaprime Private Limited
Dermaprime Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Anka Rao Pendyala was appointed as Director on 30 Jun 2022.
Credit Ratings, Litigation & Regulatory Alerts for Dermaprime Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dermaprime Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dermaprime Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dermaprime Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dermaprime Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dermaprime Private Limited
Dermaprime is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 June 2022 (4+ years old) and is registered under CIN U51909TG2022PTC164298.
Dermaprime reported revenue of ₹3.52 Cr for FY 2025 (down 10% YoY).
Dermaprime has 3 current directors:
- Narasimhachary Chowdoju - Managing Director
- Anka Rao Pendyala - Director
- Channahalli Munivenkategowda Naveen Kumar - Director
Dermaprime reported a net profit of ₹5.15 Lakh (net margin 1.5%) and EBITDA of ₹7.83 Lakh (EBITDA margin 2.2%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Dermaprime is U51909TG2022PTC164298. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dermaprime was incorporated on 30 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Dermaprime by revenue are Valcret Life Sciences Private Limited, Bioshield Lifesciences Private Limited, Success Ceramic Private Limited, Delma Innovation Private Limited, Medorna Health Systems Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Anka Rao Pendyala was appointed as Director on 30 Jun 2022. Channahalli Munivenkategowda Naveen Kumar was appointed as Director on 30 Jun 2022. Narasimhachary Chowdoju was appointed as Managing Director on 30 Jun 2022.
The registered office of Dermaprime is at 1 – 2 – 401113 Gourinathapuram, Hyderabad, Telangana, India – 500062.
Dermaprime has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.5 Lakh.
Dermaprime operates in the pharma industry, in the pharmaceutical retailers and distributors segment.